Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$529,904
-$109,926 QoQ
Shares Held
22,006
-3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,713
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $24,423,418 across 9 Drug Manufacturers - General names. PFE ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,026 | $6,355,853 | |
| 2 | LLY |
ELI LILLY & Co
|
4,609 | $5,528,173 | |
| 3 | ABBV |
AbbVie Inc.
|
21,001 | $5,284,691 | |
| 4 | AMGN |
Amgen Inc
|
11,714 | $4,241,873 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,421 | $1,596,098 | |
| 6 | PFE |
Pfizer Inc
This page
|
22,006 | $529,904 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,989 | $377,630 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,605 | $265,340 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $529,904 | 22,006 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $639,830 | 22,786 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $579,074 | 23,256 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $592,511 | 23,254 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $544,430 | 22,460 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $556,973 | 21,980 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $609,924 | 22,990 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $657,053 | 22,704 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $821,045 | 29,344 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,003,467 | 36,161 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,079,106 | 37,482 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $1,204,435 | 36,311 | Shares | Sole | 2023-12-06 | |
| 2023-06-30 | $1,459,203 | 39,782 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,608,907 | 39,434 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,054,416 | 40,094 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,789,871 | 40,902 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,285,738 | 43,596 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $2,211,407 | 42,716 | Shares | Sole | 2022-04-06 | |
| 2021-12-31 | $2,591,468 | 43,886 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,047,146 | 47,597 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $3,573,232 | 91,247 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $4,735,768 | 130,714 | Shares | Sole | 2021-05-27 | |
| 2020-12-31 | $4,432,586 | 120,418 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,847,037 | 104,824 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,323,271 | 101,629 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,927,281 | 89,684 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||